Attune Pharmaceuticals Competitors and Similar CompaniesClear all

Attune Pharmaceuticals's competitors and similar companies include Domain Therapeutics, Vigil Neuroscience, e-therapeutics and Absci.

	Attune Pharmaceuticals Attune Pharmaceuticals is a biotechnology company.	Domain Therapeutics Domain Therapeutics is a biopharmaceutical company.	Vigil Neuroscience Vigil Neuroscience is a company that discovers therapeutics for neurodegenerative diseases.	e-therapeutics e-therapeutics is a computational drug discovery company.	Absci AbSci is a company that provides generative AI drug-creation solutions.
Founding Date	Founding Date 2018	Founding Date 2001	Founding Date 2020	Founding Date 2003	Founding Date 2011
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology biotech drug development pharma	Tags Technology artificial intelligence biotech drug development platform
Locations	Locations New York, US HQ	Locations Illkirch-Graffenstaden, FR HQ Montréal, CA	Locations Cambridge, US HQ	Locations Long Hanborough, GB HQ Newcastle Upon Tyne, GB	Locations Vancouver, US HQ Belgrade, RS Zug, CH New York, US
Employees	Employees 3	Employees 811% decrease	Employees 34	Employees 58	Employees 1561% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 151.5 m	Valuation ($) N/A	Valuation ($) 487.2 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.8m (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income ($84.3m) (FY, 2024)	Net income (£14.9m) (FY, 2025)	Net income ($115.2m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 23m (over 7 years ago)	Latest funding round $ 3.9m (about 7 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 23m	Total funding raised $ 41.5m	Total funding raised $ 140m	Total funding raised $ 66.8m	Total funding raised $ 217.5m